BHWM
AMRX icon

Bay Harbor Wealth Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Bay Harbor Wealth Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$537 Buy
31
+12
+63% +$164 ﹤0.01% 1049
2026
Q1 		$236 Buy
19
+10
+111% +$134 ﹤0.01% 1134
2025
Q4 		$113 Sell
9
-5
-36% -$57 ﹤0.01% 1198
2025
Q3 		$140 Buy
14
+12
+600% +$108 ﹤0.01% 1111
2025
Q2 		$16 Buy
2
+1
+100% +$8 ﹤0.01% 1257
2025
Q1 		$8 Buy
+1
New +$8 ﹤0.01% 1142

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Bay Harbor Wealth Management's AMRX Position: Q2 2026 in Review

Bay Harbor Wealth Management increased its Amneal Pharmaceuticals (AMRX) stake by 63% in Q2 2026, buying an estimated $164 and bringing the position to 31 shares worth $537. The position accounts for ﹤0.01% of the portfolio, ranked #1049.

Bay Harbor Wealth Management first reported a position in AMRX in Q1 2025 and has held it in 6 quarters since. 306 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Bay Harbor Wealth Management held 31 shares of Amneal Pharmaceuticals worth $537 as of Q2 2026.
  • Bay Harbor Wealth Management bought 12 Amneal Pharmaceuticals shares in Q2 2026, an estimated $164.
  • Amneal Pharmaceuticals made up ﹤0.01% of Bay Harbor Wealth Management's portfolio in Q2 2026, its #1049 holding.
  • Bay Harbor Wealth Management first reported a position in Amneal Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 306 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Bay Harbor Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.